ArticleActa pharmacologica Sinica2023

SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis.

Jing-Xuan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.